Heyu Biological Technology Corporation
HYBTOTCHealthcare
$0.35
$-0.25(-41.67%)
Market Cap$361364506
P/E Ratio—
52W High$3.4
52W Low$0.002
Heyu Biological Technology Corporation（HYBT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HYBT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.87M | $2.68M | $0.08M | $0.10M | $0.22M |
| Cost of Revenue | $2.69M | $2.61M | $0.03M | $0.03M | $0.12M |
| Gross Profit | $0.18M | $0.07M | $0.05M | $0.07M | $0.10M |
| Gross Margin %(computed) | 6.34% | 2.59% | 65.31% | 68.58% | 46.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.56M | $0.54M | $0.32M | $0.00M | $0.38M |
| Total Operating Expenses | $0.56M | $0.54M | $0.32M | $0.23M | $0.38M |
| Operating Income | ($0.38M) | ($0.47M) | ($0.27M) | ($0.16M) | ($0.28M) |
| Operating Margin %(computed) | -13.16% | -17.56% | -336.63% | -168.78% | -125.28% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.03M | $0.03M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($0.49M) | ($0.45M) | ($0.27M) | ($0.16M) | ($0.75M) |
| Income Tax Expense | ($0.02M) | $0.07M | ($0.00M) | $0.00M | ($0.20M) |
| Net Income | ($0.47M) | ($0.38M) | ($0.27M) | ($0.16M) | ($0.55M) |
| Net Margin %(computed) | -16.46% | -14.16% | -336.12% | -168.97% | -246.07% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 518.83M | 450.23M | 103.25M | 103.25M | 103.25M |
| EBITDA | ($0.38M) | ($0.47M) | ($0.27M) | ($0.16M) | $0.20M |
| EBITDA Margin %(computed) | -13.15% | -17.56% | -336.63% | -168.78% | 87.79% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Heyu Biological Technology Corporation
关于Heyu Biological Technology Corporation（HYBT）损益表
Heyu Biological Technology Corporation（HYBT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，HYBT实现营收$0.00B，毛利润$0.00B（毛利率6.34%），净利润($0.00B)（净利率-16.46%）。
常见问题
HYBT · 4 问Heyu Biological Technology Corporation（HYBT）2024财年营收为$0.00B，同比up7.1%。
HYBT revenueHYBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09